FDA Issues New Guidance for Collecting Postmarketing Data on Underrepresented Patient Populations | BakerHostetler
In a notable step toward more equitable healthcare, the U.S. Food and Drug Administration (FDA) introduced new draft guidance on August 10, Postmarketing Approaches to Obtain Data on...
Source: jdsupra.com